TGF-β Promotes the Proliferation of Microglia In Vitro
Open Access
- 30 December 2019
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 10 (1) , 20
Abstract
The activation and proliferation of microglia is characteristic of the early stages of brain pathologies. In this study, we aimed to identify a factor that promotes microglial activation and proliferation and examined the in vitro effects on these processes. We cultured microglial cell lines, EOC 2 and SIM-A9, with various growth factors and evaluated cell proliferation, death, and viability. The results showed that only transforming growth factor beta (TGF-β) caused an increase in the in vitro proliferation of both microglial cell lines. It has been reported that colony-stimulating factor 1 promotes the proliferation of microglia, while TGF-β promotes both proliferation and inhibition of cell death of microglia. However, upon comparing the most effective doses of both (assessed from the proliferation assay), we identified no statistically significant difference between the two factors in terms of cell death; thus, both have a proliferative effect on microglial cells. In addition, a TGF-β receptor 1 inhibitor, galunisertib, caused marked inhibition of proliferation in a dose-dependent manner, indicating that inhibition of TGF-β signalling reduces the proliferation of microglia. Therefore, galunisertib may represent a promising therapeutic agent for the treatment of neurodegenerative diseases via inhibition of nerve injury-induced microglial proliferation, which may result in reduced inflammatory and neuropathic and cancer pain.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (No. 18K09037)
This publication has 28 references indexed in Scilit:
- Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage AccumulationPLOS ONE, 2013
- TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after strokeJournal of Neuroinflammation, 2010
- Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cellsBritish Journal of Cancer, 2009
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progressionTrends in Immunology, 2008
- Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanismProgress in Neurobiology, 2005
- Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damageProceedings of the National Academy of Sciences, 2000
- TGF-β in kidney fibrosis: A target for gene therapyKidney International, 1997
- Differential Modulation of Integrin Receptors and Extracellular Matrix Laminin by Transforming Growth Factor-β1 in Rat Alveolar Epithelial CellsExperimental Cell Research, 1995
- Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage.Stroke, 1994
- Transforming growth factor-beta: recent progress and new challenges.Journal of Cell Biology, 1992